The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results

Fabio Fulfaro; Antonio Galvano; Nicolo' Gebbia; Giuseppe Badalamenti; Chiara Intrivici; Giuseppina Valeria Albanese; Salvatore Provenzano; Simona Macaluso

The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results

Fabio Fulfaro, Antonio Galvano, Nicolo' Gebbia, Giuseppe Badalamenti, Chiara Intrivici, Giuseppina Valeria Albanese, Salvatore Provenzano, Simona Macaluso

Discipline Chirurgiche, Oncologiche e Stomatologiche

Risultato della ricerca: Other › peer review

Lingua originale	English
Pagine	S89-S89
Numero di pagine	1
Stato di pubblicazione	Published - 2010

Altri file e collegamenti

OA Link

Cita questo

@conference{c0c3e1e83b024fdda971a4ce7422df70,

title = "The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results",

keywords = "bladder cancer, bladder cancer",

author = "Fabio Fulfaro and Antonio Galvano and Nicolo' Gebbia and Giuseppe Badalamenti and Chiara Intrivici and Albanese, {Giuseppina Valeria} and Salvatore Provenzano and Simona Macaluso",

year = "2010",

language = "English",

pages = "S89--S89",

}

TY - CONF

T1 - The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results

AU - Fulfaro, Fabio

AU - Galvano, Antonio

AU - Gebbia, Nicolo'

AU - Badalamenti, Giuseppe

AU - Intrivici, Chiara

AU - Albanese, Giuseppina Valeria

AU - Provenzano, Salvatore

AU - Macaluso, Simona

PY - 2010

Y1 - 2010

KW - bladder cancer

UR - http://hdl.handle.net/10447/58510

M3 - Other

SP - S89-S89

ER -